These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 35065135)

  • 1. Review: A systematic review of virus-like particles of coronavirus: Assembly, generation, chimerism and their application in basic research and in the clinic.
    Lu W; Zhao Z; Huang YW; Wang B
    Int J Biol Macromol; 2022 Mar; 200():487-497. PubMed ID: 35065135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric Virus-like Particles of Universal Antigen Epitopes of Coronavirus and Phage Qβ Coat Protein Trigger the Production of Neutralizing Antibodies.
    Guo Y; Guo R; Ma Y; Chang W; Ming S; Yang G; Guo Y
    Curr Top Med Chem; 2021 Oct; 21(14):1235-1250. PubMed ID: 34145995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2.
    Hemmati F; Hemmati-Dinarvand M; Karimzade M; Rutkowska D; Eskandari MH; Khanizadeh S; Afsharifar A
    Biotechnol Lett; 2022 Jan; 44(1):45-57. PubMed ID: 34837582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and Application of Insect Virus-Based VLPs.
    Gopal R; Schneemann A
    Methods Mol Biol; 2018; 1776():125-141. PubMed ID: 29869238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers.
    Nooraei S; Bahrulolum H; Hoseini ZS; Katalani C; Hajizade A; Easton AJ; Ahmadian G
    J Nanobiotechnology; 2021 Feb; 19(1):59. PubMed ID: 33632278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
    Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
    Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Respiratory Syncytial Virus Phosphoprotein, Matrix Protein, and Fusion Protein Carboxy-Terminal Domain Drive Efficient Filamentous Virus-Like Particle Formation.
    Meshram CD; Baviskar PS; Ognibene CM; Oomens AGP
    J Virol; 2016 Dec; 90(23):10612-10628. PubMed ID: 27654298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational method for designing vaccines applied to virus-like particles (VLPs) as epitope carriers.
    Prosper P; Rodríguez Puertas R; Guérin DMA; Branda MM
    Vaccine; 2024 Jul; 42(18):3916-3929. PubMed ID: 38782665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of virus-like particles-based vaccines against coronaviruses.
    Yong CY; Liew WPP; Ong HK; Poh CL
    Biotechnol Prog; 2022 Nov; 38(6):e3292. PubMed ID: 35932092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.
    Liu YV; Massare MJ; Barnard DL; Kort T; Nathan M; Wang L; Smith G
    Vaccine; 2011 Sep; 29(38):6606-13. PubMed ID: 21762752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of SARS-CoV-2 virus-like particles in plant.
    Moon KB; Jeon JH; Choi H; Park JS; Park SJ; Lee HJ; Park JM; Cho HS; Moon JS; Oh H; Kang S; Mason HS; Kwon SY; Kim HS
    Sci Rep; 2022 Jan; 12(1):1005. PubMed ID: 35046461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System.
    Xu R; Shi M; Li J; Song P; Li N
    Front Bioeng Biotechnol; 2020; 8():862. PubMed ID: 32850726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus-like particles expressing Plasmodium falciparum epitopes induce complement-fixing antibodies against the circumsporozoite protein.
    Kingston NJ; Kurtovic L; Walsh R; Joe C; Lovrecz G; Locarnini S; Beeson JG; Netter HJ
    Vaccine; 2019 Mar; 37(12):1674-1684. PubMed ID: 30773400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimaeric virus-like particles derived from consensus genome sequences of human rotavirus strains co-circulating in Africa.
    Jere KC; O'Neill HG; Potgieter AC; van Dijk AA
    PLoS One; 2014; 9(9):e105167. PubMed ID: 25268783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Virus-like Particles Produced by a Single Recombinant Baculovirus Generate Anti-S Antibody and Protect against Variant Challenge.
    Sullivan E; Sung PY; Wu W; Berry N; Kempster S; Ferguson D; Almond N; Jones IM; Roy P
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
    Lyu K; He YL; Li HY; Chen R
    J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent.
    Hsieh PK; Chang SC; Huang CC; Lee TT; Hsiao CW; Kou YH; Chen IY; Chang CK; Huang TH; Chang MF
    J Virol; 2005 Nov; 79(22):13848-55. PubMed ID: 16254320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
    Garg H; Sedano M; Plata G; Punke EB; Joshi A
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.